Diagnosis & Disease Information

FDA Approves Ingrezza for Huntington Disease Chorea

Diana Ernst, RPh

August 31, 2023

Nearly half of patients receiving Ingrezza saw a more than 40% reduction in Huntington disease chorea severity by the end of the treatment period.

Neurology

Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight

Amit Akirov, MD

December 28, 2021

Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.

Next post in Neurology

Diagnosis & Disease Information

FDA Approves Ingrezza for Huntington Disease Chorea

Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight

Migraine-Diet Connection: Dietary Triggers and Interventions for Migraine Management